Global Veterinary Active Pharmaceutical Ingredients (API) Industry Research & Trends Analysis Report
According to Market IntelliX Research, the global market for Veterinary Active Pharmaceutical Ingredients (API) should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Veterinary Active Pharmaceutical Ingredients (API) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Veterinary Active Pharmaceutical Ingredients (API) market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Chemical Based API segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, CDMO has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Veterinary Active Pharmaceutical Ingredients (API) include Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group, NGL Fine-Chem Ltd, Huvepharma, Jiangsu Lingyun Pharmaceutical Co. Ltd, Excel Veterinary HealthcareVetpharma(Insud Pharma) and Menadiona, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
This report aims to provide a comprehensive study of the global market for Veterinary Active Pharmaceutical Ingredients (API). Report Highlights:
(1) Global Veterinary Active Pharmaceutical Ingredients (API) market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Veterinary Active Pharmaceutical Ingredients (API) market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Veterinary Active Pharmaceutical Ingredients (API) market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Veterinary Active Pharmaceutical Ingredients (API) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Veterinary Active Pharmaceutical Ingredients (API) segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Veterinary Active Pharmaceutical Ingredients (API), capacity, production and trends.
(7) Veterinary Active Pharmaceutical Ingredients (API) industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
Market segment by application, can be divided into
CDMO
CMO
Market segment by players, this report covers
Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
1 Market Overview
1.1 Veterinary Active Pharmaceutical Ingredients (API) Definition
1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast
1.2.1 By Revenue, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
1.2.2 By Sales Volume, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
1.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price Trend, 2019-2030
1.3 China Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast
1.3.1 By Revenue, China Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
1.3.2 By Sales Volume, China Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
1.3.3 China Veterinary Active Pharmaceutical Ingredients (API) Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Veterinary Active Pharmaceutical Ingredients (API) Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Veterinary Active Pharmaceutical Ingredients (API) Share in Global Market, 2019-2030
1.4.3 Veterinary Active Pharmaceutical Ingredients (API) Market Size: China VS Global, 2019-2030
1.5 Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
1.5.1 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
1.5.2 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
1.5.3 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
1.5.4 Veterinary Active Pharmaceutical Ingredients (API) Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company, 2019-2024
2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Company, 2019-2024
2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Company, 2019-2024
2.4 Global Veterinary Active Pharmaceutical Ingredients (API) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Veterinary Active Pharmaceutical Ingredients (API) Concentration Ratio
2.6 Global Veterinary Active Pharmaceutical Ingredients (API) Mergers & Acquisitions, Expansion Plans
2.7 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company, 2019-2024
3.2 China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Company, 2019-2024
3.3 China Veterinary Active Pharmaceutical Ingredients (API) Veterinary Active Pharmaceutical Ingredients (API) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Veterinary Active Pharmaceutical Ingredients (API) Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Veterinary Active Pharmaceutical Ingredients (API) Domestic VS Export
3.6 China Market, Veterinary Active Pharmaceutical Ingredients (API) Import & Export
3.6.1 China Market, Veterinary Active Pharmaceutical Ingredients (API) Import & Export, 2019-2030
3.6.2 China Veterinary Active Pharmaceutical Ingredients (API) Import & Export Trends
3.6.3 Main Sources of China Veterinary Active Pharmaceutical Ingredients (API) Import
3.6.4 Export Destination of China Veterinary Active Pharmaceutical Ingredients (API)
4 Veterinary Active Pharmaceutical Ingredients (API) Production by Region
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Veterinary Active Pharmaceutical Ingredients (API) Manufacturers
4.3 Global Major Manufacturers, Veterinary Active Pharmaceutical Ingredients (API) Capacity Expansion and Future Plans
4.4 Global Veterinary Active Pharmaceutical Ingredients (API) Capacity by Region
4.5 Global Veterinary Active Pharmaceutical Ingredients (API) Production by Region
4.5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Production by Region, 2019-2024
4.5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Chain
5.2 Veterinary Active Pharmaceutical Ingredients (API) Upstream Analysis
5.2.1 Veterinary Active Pharmaceutical Ingredients (API) Core Raw Materials
5.2.2 Main Manufacturers of Veterinary Active Pharmaceutical Ingredients (API) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Veterinary Active Pharmaceutical Ingredients (API) Production Mode
5.6 Veterinary Active Pharmaceutical Ingredients (API) Procurement Model
5.7 Veterinary Active Pharmaceutical Ingredients (API) Industry Sales Model and Sales Channels
5.7.1 Veterinary Active Pharmaceutical Ingredients (API) Sales Model
5.7.2 Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
6 Sights by Type
6.1 Veterinary Active Pharmaceutical Ingredients (API) Classification
6.1.1 Chemical Based API
6.1.2 Biological API
6.1.3 Highly Potent APl(HPAPI)
6.2 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030
6.4 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030
6.5 By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Price, 2019-2030
7 Sights by Application
7.1 Veterinary Active Pharmaceutical Ingredients (API) Segment by Application
7.1.1 CDMO
7.1.2 CMO
7.2 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030
7.4 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030
7.5 By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030
8.3 By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.5 Europe
8.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.7 South America
8.7.1 South America Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Veterinary Active Pharmaceutical Ingredients (API) Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030
9.3 By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.4.2 By Company, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.5.2 By Company, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.5.3 By Type, Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.6.2 By Company, China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.6.3 By Type, China Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.7.2 By Company, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.7.3 By Type, Japan Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.8.2 By Company, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.10.2 By Company, India Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.10.3 By Type, India Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Alivira Animal Health Ltd
10.1.1 Alivira Animal Health Ltd Company Information, Head Office, Market Area and Industry Position
10.1.2 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Alivira Animal Health Ltd Company Profile and Main Business
10.1.5 Alivira Animal Health Ltd Recent Developments
10.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
10.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Profile and Main Business
10.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
10.3 Procyon Life Sciences
10.3.1 Procyon Life Sciences Company Information, Head Office, Market Area and Industry Position
10.3.2 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Procyon Life Sciences Company Profile and Main Business
10.3.5 Procyon Life Sciences Recent Developments
10.4 SUANFARMAOfichem Group
10.4.1 SUANFARMAOfichem Group Company Information, Head Office, Market Area and Industry Position
10.4.2 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 SUANFARMAOfichem Group Company Profile and Main Business
10.4.5 SUANFARMAOfichem Group Recent Developments
10.5 NGL Fine-Chem Ltd
10.5.1 NGL Fine-Chem Ltd Company Information, Head Office, Market Area and Industry Position
10.5.2 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 NGL Fine-Chem Ltd Company Profile and Main Business
10.5.5 NGL Fine-Chem Ltd Recent Developments
10.6 Huvepharma
10.6.1 Huvepharma Company Information, Head Office, Market Area and Industry Position
10.6.2 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Huvepharma Company Profile and Main Business
10.6.5 Huvepharma Recent Developments
10.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
10.7.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information, Head Office, Market Area and Industry Position
10.7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.7.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Profile and Main Business
10.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
10.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
10.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information, Head Office, Market Area and Industry Position
10.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Profile and Main Business
10.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
10.9 Menadiona
10.9.1 Menadiona Company Information, Head Office, Market Area and Industry Position
10.9.2 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Menadiona Company Profile and Main Business
10.9.5 Menadiona Recent Developments
10.10 lndukern Group
10.10.1 lndukern Group Company Information, Head Office, Market Area and Industry Position
10.10.2 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 lndukern Group Company Profile and Main Business
10.10.5 lndukern Group Recent Developments
10.11 LasaSupergenerics Ltd.
10.11.1 LasaSupergenerics Ltd. Company Information, Head Office, Market Area and Industry Position
10.11.2 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
10.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 LasaSupergenerics Ltd. Company Profile and Main Business
10.11.5 LasaSupergenerics Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Veterinary Active Pharmaceutical Ingredients (API) Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
Table 3. Veterinary Active Pharmaceutical Ingredients (API) Market Trends
Table 4. Veterinary Active Pharmaceutical Ingredients (API) Industry Policy
Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company, 2019-2024, US$ million
Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Company, 2019-2024
Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Company, 2019-2024
Table 9. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Veterinary Active Pharmaceutical Ingredients (API) Mergers & Acquisitions, Expansion Plans
Table 12. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Product Type
Table 13. China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company, 2019-2024, US$ million
Table 14. China Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Company, 2019-2024
Table 15. China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Veterinary Active Pharmaceutical Ingredients (API) Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Veterinary Active Pharmaceutical Ingredients (API) Import & Export Trends
Table 19. Main Sources of China Veterinary Active Pharmaceutical Ingredients (API) Import
Table 20. Export Destination of China Veterinary Active Pharmaceutical Ingredients (API)
Table 21. Global Headquarters and Manufacturing Base of Veterinary Active Pharmaceutical Ingredients (API) Manufacturers
Table 22. Global Major Manufacturers, Veterinary Active Pharmaceutical Ingredients (API) Capacity Expansion and Future Plans
Table 23. Global Veterinary Active Pharmaceutical Ingredients (API) Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Veterinary Active Pharmaceutical Ingredients (API) Production by Region, 2019-2024, (K Units)
Table 25. Global Veterinary Active Pharmaceutical Ingredients (API) Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Veterinary Active Pharmaceutical Ingredients (API) Upstream (Raw Materials)
Table 27. Global Veterinary Active Pharmaceutical Ingredients (API) Typical Customers
Table 28. Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
Table 29. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2019-2030
Table 37. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2019-2030
Table 39. Alivira Animal Health Ltd Company Information, Head Office, Market Area and Industry Position
Table 40. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 41. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Alivira Animal Health Ltd Company Profile and Main Business
Table 43. Alivira Animal Health Ltd Recent Developments
Table 44. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 46. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Profile and Main Business
Table 48. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
Table 49. Procyon Life Sciences Company Information, Head Office, Market Area and Industry Position
Table 50. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 51. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Procyon Life Sciences Company Profile and Main Business
Table 53. Procyon Life Sciences Recent Developments
Table 54. SUANFARMAOfichem Group Company Information, Head Office, Market Area and Industry Position
Table 55. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 56. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. SUANFARMAOfichem Group Company Profile and Main Business
Table 58. SUANFARMAOfichem Group Recent Developments
Table 59. NGL Fine-Chem Ltd Company Information, Head Office, Market Area and Industry Position
Table 60. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 61. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. NGL Fine-Chem Ltd Company Profile and Main Business
Table 63. NGL Fine-Chem Ltd Recent Developments
Table 64. Huvepharma Company Information, Head Office, Market Area and Industry Position
Table 65. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 66. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Huvepharma Company Profile and Main Business
Table 68. Huvepharma Recent Developments
Table 69. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information, Head Office, Market Area and Industry Position
Table 70. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 71. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Profile and Main Business
Table 73. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
Table 74. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information, Head Office, Market Area and Industry Position
Table 75. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 76. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Profile and Main Business
Table 78. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
Table 79. Menadiona Company Information, Head Office, Market Area and Industry Position
Table 80. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 81. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Menadiona Company Profile and Main Business
Table 83. Menadiona Recent Developments
Table 84. lndukern Group Company Information, Head Office, Market Area and Industry Position
Table 85. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 86. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. lndukern Group Company Profile and Main Business
Table 88. lndukern Group Recent Developments
Table 89. LasaSupergenerics Ltd. Company Information, Head Office, Market Area and Industry Position
Table 90. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Models, Specifications and Application
Table 91. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. LasaSupergenerics Ltd. Company Profile and Main Business
Table 93. LasaSupergenerics Ltd. Recent Developments
List of Figure
Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Picture
Figure 2. By Revenue, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Veterinary Active Pharmaceutical Ingredients (API) Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Veterinary Active Pharmaceutical Ingredients (API) Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Veterinary Active Pharmaceutical Ingredients (API) Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Veterinary Active Pharmaceutical Ingredients (API) Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Veterinary Active Pharmaceutical Ingredients (API) Share of Global Market, 2019-2030
Figure 10. Global Veterinary Active Pharmaceutical Ingredients (API) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Veterinary Active Pharmaceutical Ingredients (API) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Veterinary Active Pharmaceutical Ingredients (API) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Veterinary Active Pharmaceutical Ingredients (API) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Veterinary Active Pharmaceutical Ingredients (API) Domestic VS Export, 2022
Figure 16. Global Veterinary Active Pharmaceutical Ingredients (API) Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Veterinary Active Pharmaceutical Ingredients (API) Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Veterinary Active Pharmaceutical Ingredients (API) Production Market Share & Forecast by Region, 2019-2030
Figure 19. Veterinary Active Pharmaceutical Ingredients (API) Industry Chain
Figure 20. Veterinary Active Pharmaceutical Ingredients (API) Procurement Model
Figure 21. Veterinary Active Pharmaceutical Ingredients (API) Sales Model
Figure 22. Veterinary Active Pharmaceutical Ingredients (API) Sales Channels, Direct Sales and Distribution
Figure 23. Chemical Based API
Figure 24. Biological API
Figure 25. Highly Potent APl(HPAPI)
Figure 26. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030, US$ Million
Figure 27. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2019-2030
Figure 28. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 29. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2019-2030
Figure 30. By Type, Global Veterinary Active Pharmaceutical Ingredients (API) Price, 2019-2030, (US$/Unit)
Figure 31. CDMO
Figure 32. CMO
Figure 33. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue, 2019-2030, US$ Million
Figure 34. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2019-2030
Figure 35. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 36. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2019-2030
Figure 37. By Application, Global Veterinary Active Pharmaceutical Ingredients (API) Price, 2019-2030, (US$/Unit)
Figure 38. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2019-2030
Figure 39. By Region, Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2019-2030
Figure 40. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue & Forecasts, 2019-2030, US$ Million
Figure 41. By Country, North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2022
Figure 42. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue & Forecasts, 2019-2030, US$ Million
Figure 43. By Country, Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2022
Figure 44. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2022
Figure 46. South America Veterinary Active Pharmaceutical Ingredients (API) Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, South America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share, 2022
Figure 48. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 50. By Company, U.S. Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 51. By Type, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, Europe Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 55. By Type, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 57. China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, China Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 59. By Type, China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, Japan Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 63. By Type, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, South Korea Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 67. By Type, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 71. By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 73. India Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, India Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 75. By Type, India Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Market Share, 2022
Figure 79. By Type, Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|